Stocks Missing Out on Europe's Good Newshttp://www.fool.com/investing/general/2012/07/02/stocks-missing-out-on-europes-good-news.aspx Rich Duprey
July 2, 2012
It's difficult to think there are stocks that tumbled on a day when the Dow Jones Industrial Average surged 277 points, or 2.2%, after Germany caved to demands from Italy and Spain to be bailed out or face the prospect of their blocking "everything." Yet some companies did manage to go in the other direction Friday, and by fairly significant percentages.
But let's see whether they had good reason to drop and sit out the crazy ride up, as panic-fueled declines can sometimes make for excellent buying opportunities.
A demand economy
And once again there was nothing to drive Osiris Therapeutics down again for the second time in three days. It was likely more profit-taking after the huge run-up in its stock over the past month after getting its Prochymal treatment approved in Canada and New Zealand. The stock has doubled year to date and there's no reason to expect it will continue losing all those gains.
It was the same situation at Suntech Power, where there was nothing to account for the stock's drop, although a Bloomberg article noted that renewable energy "investments" may double in Japan beginning July 1, as new subsidies take effect. However, one analyst said Japan needs to follow Europe's lead and cut its subsidies, since it currently receives triple the tariffs other renewable forms of energy do. I've been bearish on solar stocks for a while and have rated Suntech to underperform the market on CAPS since the beginning of the year. Friday's decline only adds to my winning CAPSCall.
I've been similarly bearish for a similar length of time on lithium-ion battery maker A123 Systems, believing the electric vehicle market isn't as ready for prime time as its proponents hope. That call has also served me well on CAPS, and I wrote two weeks ago that I felt it was going to go bankrupt sooner than later. On Friday, analysts at Wunderlich Securities confirmed that the new and improved batteries it was developing -- you can forget all those others it had built and then had to recall -- likely wouldn't arrive before it ran out of money. The analyst excoriated the company and assigned it a $0.50 price target, and said it "would be zero except that we believe the factory has so